Decrease in LDL receptor-related protein expression and function correlates with advanced stages of Wilms tumors.

Area of Science:

• Oncology
• Molecular Biology
• Pediatric Cancer Research

Background:

• The molecular basis of Wilms tumor (WT) invasiveness is not fully understood.
• While WT1 gene mutations are implicated, they don't entirely explain tumor growth.
• New molecular factors regulating WT invasiveness need identification.

Purpose of the Study:

• To identify novel molecular players involved in the invasive phenotype of pediatric Wilms tumors.
• To investigate the role of specific proteins in WT tumor progression and metastasis.

Main Methods:

• Analysis of 45 fresh frozen Wilms tumor samples from different stages (III, IV, anaplastic).
• Techniques included gelatin zymography, Western blotting, and immunodetection.
• Comparison of protein expression between infiltrating, metastatic, and anaplastic WT phenotypes.

Main Results:

• Decreased expression of low-density lipoprotein receptor-related protein (LRP) and its chaperone RAP in advanced stage (IV) and anaplastic WT.
• Reduced LRP/RAP correlated with elevated levels of extracellular matrix ligands (PAI-1, MMP-9, TIMP-1).
• Proteolytic processing of MT1-MMP, an LRP regulator, also correlated with WT invasiveness.

Conclusions:

• Low LRP expression, influenced by MT1-MMP, may drive the invasive potential of Wilms tumors.
• Diminished LRP's role in recycling extracellular matrix proteolytic enzymes is critical in advanced WT stages.
• These findings offer insights into the molecular mechanisms of pediatric kidney cancer invasiveness.